Navigation Links
Biorem Reports Sale of Securities by Major Shareholders
Date:6/27/2016

GUELPH, ON, June 27, 2016 /PRNewswire/ - BIOREM Inc. (TSX-V: BRM) ("Biorem" or "the Company") announces that it has been advised by its major shareholders, Clean Technology Fund I, LP and Clean Technology Fund II, LP, United States based venture capital funds which together hold approximately 59% of the common shares of Biorem (on a fully diluted, as converted basis), that they have entered into an agreement for the disposition of their entire equity holdings in Biorem to TUS Holdings Co. Ltd. ("TUS") (en.tusholdings.com) at a purchase price equivalent to $0.345 per common share. Biorem understands that the sale is subject to certain closing conditions including (i) any approvals required from the TSX Venture Exchange ("TSXV"), (ii) the resignation of Bernardo Llovera from the board of directors of Biorem, (iii) the expansion of the board of directors to five members and (iv) the appointment of two directors nominated by TUS to the board of directors. Biorem is not a party to the transaction and has made an application to TSXV for confirmation that the only approval required from the TSXV in respect of the transaction is the approval of TUS as a new insider of Biorem. 

About BIOREM Inc.

BIOREM is a leading clean technology company that designs, manufactures and distributes a comprehensive line of high-efficiency air emissions control systems used to eliminate odors, volatile organic compounds (VOCs), and hazardous air pollutants (HAPs). With sales and manufacturing offices across the continent, a dedicated research facility, a worldwide sales representative network and more than 1000 installed systems worldwide, BIOREM offers state-of-the-art technology-based products and peace of mind for municipalities, industrial companies and their surrounding communities. Additional information on Biorem is available on our website at www.biorem.biz.


'/>"/>
SOURCE Biorem Inc.
Copyright©2016 PR Newswire.
All rights reserved


Related biology technology :

1. DryLet Technologies Announces Website Launch and New Logo Design for Patented MB Bioremediation
2. DryLet to Attend UpTech Upstream Oil and Gas Summit on October 6-8, 2013 in Alberta to Showcase MB Bioremediation
3. Biorem Reports 2014 Second Quarter Results
4. BIOREM announces $2.1 million of new orders
5. BIOREM announces $1.4 million of new orders
6. BIOREM announces additional orders for $1.7 million
7. Biorem Reports Third Quarter Results
8. Synthetic Biology Market by Tool, Technology (Bioinformatics, Nanotechnology, Gene Synthesis, Cloning & Sequencing), Application (Biofuels, Pharmaceuticals, Biomaterials, Bioremediation) - Global Forecast to 2018
9. BIOREM announces orders for $3.7 million.
10. Biorem Engineering and Syngulon Sign a Strategic Partnership: The Alliance of Green Chemistry and White Biotechnology
11. Biorem Reports Results for Fourth Quarter 2014 and Year Ended December 31, 2014
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... -- On Thursday, March 23, 2017, the ... 0.07%; the Dow Jones Industrial Average edged 0.02% lower, ... at 2,345.96, marginally dropping 0.11%. US markets saw a ... sectors finished in red, and 1 sector ended flat ... coverage on the following Biotechnology equities: BioDelivery Sciences International ...
(Date:3/23/2017)... Research and Markets has announced the addition of ... offering. ... The Global Market for Bioproducts Should Reach $714.6 Billion ... of 8.9%, This research report quantifies the ... product segments: bio-derived chemicals, biofuels, pharmaceuticals (biodrugs and herbal/botanicals), biocomposite ...
(Date:3/23/2017)... ... 23, 2017 , ... Ellen Matloff, president and CEO of ... as a 2017 Women of Innovation® finalist. Matloff will be among several women ... The dinner recognizes women accomplished in science, technology, engineering and math (STEM), along ...
(Date:3/23/2017)... 2017 In today,s pre-market research, ... the Biotech industry: Sangamo Therapeutics Inc. (NASDAQ: SGMO), Eyegate ... SYN), and Regulus Therapeutics Inc. (NASDAQ: RGLS ... Suisse upgraded its rating on Pharmaceuticals/Biotechnology to "Overweight" from "Market Weight." Learn ... at: ...
Breaking Biology Technology:
(Date:3/22/2017)... 21, 2017 Vigilant Solutions , a ... enforcement agencies, announced today the appointment of retired FBI ... public safety business development. Mr. Sheridan brings ... including a focus on the aviation transportation sector, to ... position, Mr. Sheridan served as the Aviation Liaison Agent ...
(Date:3/9/2017)... , Australia , March 9, ... study data at the prestigious World Lung Imaging Workshop ... Andreas Fouras , was invited to deliver the ... pulmonary medicine. This globally recognised event brings together leaders ... share the latest developments in lung imaging. ...
(Date:3/2/2017)... YORK , March 2, 2017 Summary ... better understand Perrigo and its partnering interests and activities since ... ... Partnering Deals and Alliance since 2010 report provides an in-depth ... leading life sciences companies. On demand company reports ...
Breaking Biology News(10 mins):